Cosmetic & Toiletry Wholesale

The success of the Drug, Cosmetic and Toiletry Wholesaling industry is driven by demand for its primary product segment, pharmaceuticals. The largest percentage of industry revenue is derived from the distribution of prescription and nonprescription drugs to a variety of retailers and healthcare providers. Over the five years to 2022, several major brand-name drugs have lost patent exclusivity which has created an opportunity for less expensive generic drugs on the market. Nonetheless, wholesalers have countered by adjusting their prices and supplies accordingly.Consequently, industry revenue is expected to rise an annualized 2.5% to $1.2 trillion over the five years to 2022.Revenue during this period has been boosted by the COVID-19 (coronavirus) pandemic that started in late 2019.Revenue increased 4.0% and 4.7% in 2020 and 2021, respectively. In 2022 alone, industry revenue is expected to decrease 0.5%.